Clinical Trials Directory

Trials / Completed

CompletedNCT04523675

NAC Supplementation and Soccer Specific Performance

Effects of NAC Supplementation on Immune Function, Inflammatory and Performance Responses of Elite Soccer Players Participated in Three Repetitive Games.

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
40 (actual)
Sponsor
University of Thessaly · Academic / Other
Sex
Male
Age
18 Years – 28 Years
Healthy volunteers
Accepted

Summary

In this investigation the investigators utilized NAC supplementation to boost GSH availability during an one-week-microcycle consisting of three soccer games, in order to test the hypotheses that: i) antioxidant supplementation may enhance the recovery of performance and physiological stress variables following multiple match-plays and ii) redox status perturbations are critical in regulating the inflammatory response and repair in skeletal muscle, following repetitive exercise-induced muscle injuries.

Detailed description

After exercise-induced muscle microtrauma the thiol/disulfide couple of reduced (GSH) and oxidized glutathione (GSSG) is a key regulator of important transcriptional pathways that control the inflammatory response and recovery of skeletal muscle. The objective was to examine how thiol-based antioxidant supplementation affects the muscle damage, oxidative stress, inflammatory and immune responses, as well as the level of post-game fatigue and muscle's recovery kinetics in response to three soccer games within a week. Participants were randomly assigned to one of four groups: i) Experimental-NAC \[EXP-NAC, N=10, participated in daily training sessions and three games and received NAC (20 mg/kg/day)\], ii) Experimental-Placebo (EXP-Pla, N=10, participated in daily training sessions and three games and received Placebo), iii) Control-NAC \[CON-NAC, N=10, participated in daily training sessions only and received NAC(20 mg/kg/day)\] and iv) Control-Placebo (CON-Pla, N=10, participated in daily training sessions only and received Placebo). Blood samples were collected at baseline, post-games and daily during recovery. Performance was assessed at baseline and daily during recovery.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTN-acetylcysteineOrally in three daily dosages (morning-midday-evening), at 20 mg/kg/day, for seven consecutive days.
DIETARY_SUPPLEMENTPlacebo500 mL drink that contained water (375 mL), sugar-free cordial (125 ml), and 2 g of low-calorie glucose/dextrose powder. Orally in three daily dosages (morning-midday-evening), for seven consecutive days.

Timeline

Start date
2016-04-01
Primary completion
2016-07-01
Completion
2016-12-01
First posted
2020-08-21
Last updated
2020-08-21

Locations

1 site across 1 country: Greece

Source: ClinicalTrials.gov record NCT04523675. Inclusion in this directory is not an endorsement.